Naloxone in the Treatment of Anorexia Nervosa: Effect on Weight Gain and Lipolysis
Open Access
- 1 February 1981
- journal article
- other
- Published by SAGE Publications in Journal of the Royal Society of Medicine
- Vol. 74 (2) , 129-131
- https://doi.org/10.1177/014107688107400208
Abstract
The effects of a constant intravenous infusion of naloxone in doses ranging from 3.2 to 6.4 mg/day were studied in a group of patients with anorexia nervosa. Patients showed a significantly greater weight gain during the infusion compared with the periods before and after naloxone. Plasma fJ-hydroxybutyrate and non-esterified fatty acid levels fell during the infusion. It is suggested that, in man, naloxone has an antilipolytic effect in vivo.This publication has 5 references indexed in Scilit:
- SERUM T3 AND T4 LEVELS IN PATIENTS WITH ANOREXIA NERVOSA SHOWING TRANSIENT HYPERTHYROIDISM DURING WEIGHT GAINClinical Endocrinology, 1979
- In vitro lipolytic activity of porcine β‐endorphin not mediated by an opiate receptorFEBS Letters, 1979
- The anti-ketotic effect of opiate receptor blockade by naloxone infusion in human diabetes [proceedings].1977
- Enzymic determination of d(−)-β-hydroxybutyric acid and acetoacetic acid in bloodBiochemical Journal, 1962
- Microdetermination of Long-chain Fatty Acids in Plasma and TissuesJournal of Biological Chemistry, 1960